Budget Impact Analysis of Tocilizumab Versus Adalimumab As A First Line (1l) Monotherapy For The Treatment of Patients With Rheumatoid Arthritis (Ra) In Greece
Abstract
Authors
A Argyriou L Papageorgiou E Argyropoulos A Skroumpelos X Caporis